Cargando…

Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic

Detalles Bibliográficos
Autores principales:	Kang, Lois, Goldman, Maya, Uyehara, Anny, Goldman, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849591/ http://dx.doi.org/10.1016/j.jaci.2020.12.603

Ejemplares similares

Continuing Peanut Oral Immunotherapy via Telemedicine During the COVID-19 Pandemic
por: Schoonover, Anna, et al.
Publicado: (2021)

Gaps in allergen immunotherapy administration and subcutaneous allergen immunotherapy dose adjustment schedules: Need for prospective data
por: Larenas-Linnemann, Désirée Erlinda, et al.
Publicado: (2020)

Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age
por: Morais-Almeida, Mário, et al.
Publicado: (2016)

Comparative study of novel dosing schedules for interrupted immunotherapy for allergic rhinitis
por: Xi, Lin, et al.
Publicado: (2022)

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
por: Alsolaihim, Alanood, et al.
Publicado: (2020)

FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies
por: Zuidmeer-Jongejan, Laurian, et al.
Publicado: (2012)

198 AAAAI Survey on Immunotherapy Practice Patterns Concerning Dosing, Dose-Adjustment after Missed Doses and Duration of Immunotherapy
por: Linnemann, Désirée Larenas, et al.
Publicado: (2012)

Neurologic manifestations in anaphylaxis due to subcutaneous allergy immunotherapy: A case report
por: Mangold, Michelle, et al.
Publicado: (2018)

Simultaneous up‐dosing of bee and vespid venom immunotherapy is safe
por: Čerpes, Urban, et al.
Publicado: (2019)

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Neutralizing anti-Tat antibodies prolonged HAART interruption in vaccines in a prospective structured interruption study
por: Clumeck, Nathan, et al.
Publicado: (2006)

Uterine Anaphylaxis Due to Subcutaneous Immunotherapy (SCIT) for Inhalant Allergens: A Case Series
por: Ganguli, Malika P, et al.
Publicado: (2023)

Fanconi syndrome due to prolonged use of low-dose adefovir
por: Wang, Xiao-Bing, et al.
Publicado: (2015)

Ultrarush immunotherapy with polymerized extracts during the coronavirus disease 2019 pandemic: Safety of restarting administrations without dose adjustments
por: Bragança, Mariana, et al.
Publicado: (2022)

A modeling‐based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study
por: Keutzer, Lina, et al.
Publicado: (2022)

Tacrolimus dose adjustment is not necessary in dose to dose conversion from a twice daily to a prolonged release once daily dose form
por: Tiankanon, Kanitha, et al.
Publicado: (2022)

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]
por: Stein, R. C., et al.
Publicado: (1991)

Efficacy and safety of tildrakizumab for plaque psoriasis with continuous dosing, treatment interruption, dose adjustments and switching from etanercept: results from phase III studies
por: Kimball, A.B., et al.
Publicado: (2019)

Interrupted cochlear implant habilitation due to COVID-19 pandemic-ways and means to overcome this
por: Dham, Ruchima, et al.
Publicado: (2020)

Empyema Necessitans due to Interruption of Antituberculosis Treatment
por: Benaragama, H. N., et al.
Publicado: (2019)

Adjusting the dose of traditional drugs combined with immunotherapy: reshaping the immune microenvironment in lung cancer
por: Wang, Linlin, et al.
Publicado: (2023)

A Case of Subcutaneous Emphysema
por: Visscher, Lois H.
Publicado: (1946)

Perspectives on COVID-19 and cancer immunotherapy: a review series
por: Goldman, Jason D, et al.
Publicado: (2021)

Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters
por: Puricelli Perin, Douglas M., et al.
Publicado: (2021)

Prolonged Interruption of Cognitive Control of Conflict Processing Over Human Faces by Task-Irrelevant Emotion Expression
por: Kim, Jinyoung, et al.
Publicado: (2017)

Cancer Immunotherapy and Personalized Medicine: Emerging Technologies and Biomarker-Based Approaches
por: Maciejko, Laura, et al.
Publicado: (2017)

Efficacy of Sublingual Immunotherapy versus Subcutaneous Injection Immunotherapy in Allergic Patients
por: Saporta, Diego
Publicado: (2012)

Compensation for radiotherapy treatment interruptions due to a cyberattack: An isoeffective DVH‐based dose compensation decision tool
por: O'Shea, Katie, et al.
Publicado: (2022)

Effect of radiotherapy interruption due to COVID-19 outbreak
por: Yu, Dongdong, et al.
Publicado: (2021)

Subcutaneous Immunotherapy Improves the Symptomatology of Allergic Rhinitis
por: Lourenço, Edmir Américo, et al.
Publicado: (2015)

Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
por: Tsabouri, Sophia, et al.
Publicado: (2017)

Safe and effective subcutaneous adipolysis in minipigs by a collagenase derivative
por: Chen, Fuding, et al.
Publicado: (2019)

Severe pneumomediastinum and subcutaneous emphysema subsequent to prolonged mechanical ventilation
por: Fidrocki, Diana M., et al.
Publicado: (2021)

Mitigate risks of medication interruption due to COVID‐19 for elderly with chronic diseases
por: Hsiao, Shih‐Huai, et al.
Publicado: (2020)

Impact of botulinum toxin consultation interruption due to the COVID-19 pandemic on patients' perceptions of therapeutic goals
por: Ferreira, Eduardo Freitas, et al.
Publicado: (2021)

Real-life adherence to subcutaneous immunotherapy: What has changed in the era of the COVID-19 pandemic
por: Koca Kalkan, Ilkay, et al.
Publicado: (2021)

RARE-28. The use of subcutaneous interferon in patients with craniopharyngioma: an institutional retrospective review
por: Patil, Prabhumallikarjun, et al.
Publicado: (2022)

A pandemic business interruption insurance
por: Louaas, Alexis, et al.
Publicado: (2023)

Effects of Acute Prolonged Sitting and Interrupting Prolonged Sitting on Heart Rate Variability and Heart Rate in Adults: A Meta-Analysis
por: Bates, Lauren C., et al.
Publicado: (2021)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j1uamj2cklul7u18di0rgc6mka